A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A combination of methylation and protein markers is capable of detecting gastric cancer detection by combined markers
Authors
Keywords
-
Journal
Epigenomics
Volume 13, Issue 19, Pages 1557-1570
Publisher
Future Medicine Ltd
Online
2021-10-11
DOI
10.2217/epi-2021-0080
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location
- (2017) Lele Song et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis
- (2017) Yuting Wu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening
- (2017) Lele Song et al. Epigenomics
- Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer
- (2017) Fuminori Sonohara et al. Oncology Letters
- The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
- (2017) Lele Song et al. Scientific Reports
- Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
- (2017) Luka de Vos et al. Clinical Epigenetics
- Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments
- (2017) P. Verdier-Pinard et al. Scientific Reports
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA Methylation in Cancer and Aging
- (2016) M. Klutstein et al. CANCER RESEARCH
- Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening
- (2016) Dong Wu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients
- (2016) Saki Matsui et al. ONCOLOGY REPORTS
- Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter
- (2016) Jingyu Deng et al. Oncotarget
- Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis
- (2016) Fang Han et al. Oncotarget
- Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
- (2016) Yao Liang et al. Oncotarget
- Tumor Markers for Diagnosis, Monitoring of Recurrence and Prognosis in Patients with Upper Gastrointestinal Tract Cancer
- (2015) Jie-Xian Jing et al. Asian Pacific Journal of Cancer Prevention
- Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of E3 ubiquitin ligase RNF180 DNA promoter to predict the survival of gastric cancer
- (2015) Xing-Ming Xie et al. Cancer Biomarkers
- Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm
- (2015) Peng Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
- (2015) Bernd Schmidt et al. PLoS One
- Methylation of CpG sites in RNF180 DNA promoter prediction poor survival of gastric cancer
- (2015) Jingyu Deng et al. Oncotarget
- Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future
- (2014) Yuemin Li et al. Biomarkers in Medicine
- Postoperative serum methylation levels ofTAC1andSEPT9are independent predictors of recurrence and survival of patients with colorectal cancer
- (2014) CheeKian Tham et al. CANCER
- Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients
- (2014) I-Ying Kuo et al. International Journal of Medical Sciences
- Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
- (2014) Tomasz Powrózek et al. MEDICAL ONCOLOGY
- Circulating Methylated Septin 9 Nucleic Acid in the Plasma of Patients with Gastrointestinal Cancer in the Stomach and Colon
- (2014) Hye Seung Lee et al. Translational Oncology
- Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population
- (2014) Xin-Zu Chen et al. TUMOR BIOLOGY
- Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer
- (2014) XIE ZHANG et al. Oncology Letters
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
- (2013) Dimo Dietrich et al. PLoS One
- Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population
- (2012) Xin-Zu Chen et al. MOLECULAR BIOLOGY REPORTS
- Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers
- (2012) Kinga Tóth et al. PLoS One
- Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
- (2011) Katja U Schneider et al. BMC CANCER
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Characterization of the gene structure, functional significance, and clinical application ofRNF180, a novel gene in gastric cancer
- (2011) Kin-Fai Cheung et al. CANCER
- Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination
- (2011) Shigenobu Emoto et al. Gastric Cancer
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started